S&P 500
(-0.88%) 4 967.23 points
Dow Jones
(0.56%) 37 986 points
Nasdaq
(-2.05%) 15 282 points
Oil
(0.12%) $83.24
Gas
(0.46%) $1.760
Gold
(-0.29%) $2 406.70
Silver
(-0.34%) $28.75
Platinum
(-0.05%) $943.30
USD/EUR
(-0.12%) $0.938
USD/NOK
(-0.28%) $11.01
USD/GBP
(0.52%) $0.808
USD/RUB
(-0.74%) $93.20

Sanntidsoppdatering for Response Genetics, Inc [RGDXQ]

Børs: OTC Sektor: Healthcare Industri: Diagnostics & Research
Sist oppdatert15 mai 2023 @ 18:32

0.00% $ 0.0000010

Live Chart Being Loaded With Signals

Commentary (15 mai 2023 @ 18:32):

Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally...

Stats
Dagens volum 77 000.00
Gjennomsnittsvolum 0.00
Markedsverdi 116.00
EPS $-0.108 ( 2015-03-31 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0 (0.00%)

Volum Korrelasjon

Lang: -0.48 (neutral)
Kort: 0.00 (neutral)
Signal:(51.968) Neutral

Response Genetics, Inc Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Response Genetics, Inc Korrelasjon - Valuta/Råvare

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )

Response Genetics, Inc Økonomi

Annual 2015
Omsetning: $18.04M
Bruttogevinst: $3.94M (21.85 %)
EPS: $-0.521
Q1 2015
Omsetning: $3.79M
Bruttogevinst: $1.48M (38.94 %)
EPS: $-0.100
Q4 2014
Omsetning: $4.08M
Bruttogevinst: $1.63M (40.07 %)
EPS: $-0.0900
Q3 2014
Omsetning: $4.46M
Bruttogevinst: $1.92M (43.05 %)
EPS: $-0.0900

Financial Reports:

No articles found.

Response Genetics, Inc

Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.